Pharmaceuticals Headlines from PR Newswire

< Go Back

Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making
Building a Best-in-Class Pharma Global Brand Website
AbbVie Receives U.S. FDA Approval of VIEKIRA PAK™ (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C
Hospira to Present at the J.P. Morgan 33rd Annual Healthcare Conference Jan. 14, 2015
XYDALBA™ (dalbavancin) Receives CHMP Positive Opinion for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in Adults
Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd.
Advanced Medical Isotope Corporation Awarded LSDF Grant As Commercialization Partner
Aegate Appoints new CTO and Chief Channels & Partner Officer
Bina Technologies is acquired by Roche.
Roche acquires Bina Technologies and enters the genomic informatics market
Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference
Wounds Therapeutic Pipeline H2 2014 Review in New Market Research Report
Regeneron Announces Presentation and Panel Discussion at the 33rd Annual J.P. Morgan Healthcare Conference
Actavis to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Xarelto Attorney News Update: U.S. Judicial Panel Has Centralized Xarelto Lawsuits Filed Nationally in Louisiana
Translarna Granted Orphan Drug Designation in the U.S. and Europe for the Treatment of Mucopolysaccharidosis I
OncoGenex Announces Results from the Phase 2 Borealis-1™ Trial of Apatorsen in the Treatment of Metastatic Bladder Cancer
CHMP Recommends Approval of Xadago™ (Safinamide) to Treat Parkinson´s Disease in the EU
Orexigen's Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) Receives Positive CHMP Opinion Recommending Approval for Weight Management in the European Union
Sorrento and Conkwest Announce Exclusive Global Collaboration
Monarch America Inc. CEO Reviews Recent Achievements and Provides Outlook for 2015
Separation Membranes Market (Company, Country & Application) Research Reports for Global and Chinese Regions
New Possibilities in the Fight Against Pancreatic Cancer
Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology
Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis
Post Silk Road - Another Online Drug Den Now Dominates the DarkNet
Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Receives Orphan Drug Designation in the United States and the European Union for the Treatment of Malignant Pleural Mesothelioma
Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue
Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products
Bayer Appoints Cardinal Health as U.S. Based Contract Manufacturer for Xofigo® (radium Ra 223 dichloride) Injection
AMC Health Names Paul Argay Chief Marketing Officer, Adding to Strong Executive Management Team
NorthStar Anesthesia Acquires AmSol, Expands Presence in Southeast and Midwest
ABIVAX, a Privileged Partner of the Cuban Life Science Industry, Welcomes Initiative to Renew Relations Between the USA and Cuba
Androgenic Alopecia Therapeutic Companies and Drugs Pipeline H2 2014 Review Research Report
TPI New Qionglai Facility (QLF) Updates
Pharmacists Provide Important Information and Care During Cold and Flu Season
PDS Biotechnology, Inc. Announces Appointment of Biotech Industry Leader Sir Richard Sykes to its Board of Directors as Executive Chairman
Putney Launches Carprofen Chewable Tablets
Advanced Molecular Diagnostics Company, Admera Health, Implements WaferGen's Next-Generation Sequencing Sample Prep Platform for Clinical Testing
Cannabics Pharmaceuticals engages with Mountain High Products in Colorado
Biotech Stocks Technical Insight -- ARIAD Pharma, Geron, PDL BioPharma, Cytori Therapeutics, and Navidea Biopharma
$12M Investment in Orphan Drug Company Nutrinia, Brings Hope to Pre-term and Short Bowel Syndrome Infants
Abbott to Present at J.P. Morgan Healthcare Conference
New Report: Decades of Drug Research Failures and Successes Transform Hepatitis C from Incurable to Curable Disease
U.S. Legalized Cannabis Industry Estimated to be Worth Over $2 Billion in 2014 as Licensed Medical Marijuana Operators Grow Exponentially
SomaGenics Receives $2,275,000 in NIH Funding to Develop its RNAi Therapeutics and microRNA Technologies
Protagonist Therapeutics Names William A. Hodder as Senior Vice President, Corporate Development
HUYA Bioscience International Establishes Alliance with China Wuqing Development Area
Claritas Genomics Appoints Patrick F. Terry as Chief Commercial Officer
D-Pharm Achieves Primary End-point in Phase 2 Clinical Study of THR-18 in Acute Stroke Patients Treated With tPA

< Prev Next >
PR Newswire - United Business Media